Canada Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2012

Canada Endoscopy Devices Investment Opportunities, Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to the Canada Endoscopy Devices devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the Endoscopy Devices in Canada

Scope

• The report provides endoscopy devices information broken down into detailed categories and segments in Canada.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the endoscopy devices market in Canada.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

• 1 Table Of Contents
• 1 Table Of Contents
  • 1.1 List of Tables
  • 1.2 List of Figures
• 2 Introduction
  • 2.1 What Is This Report About?
  • 2.2 Definitions
    • 2.2.1 Endoscopy Devices
      • 2.2.1.1 Flexible Endoscope
      • 2.2.1.2 Rigid Endoscope
• 3 Healthcare Sector Review
  • 3.1 Healthcare Sector Review
  • 3.2 Healthcare Expenditure
  • 3.3 Healthcare Infrastructure
• 4 Endoscopy Devices in Canada
  • 4.1 Endoscopy Devices Overall Revenues (2000-2012)
  • 4.2 Endoscopy Devices Overall Volume (2000-2012)
  • 4.3 Endoscopy Devices Overall Company Share (2006-2007)
• 5 Flexible Endoscope in Canada
  • 5.1 Flexible Endoscope Overall Revenue (2000-2012)
  • 5.2 Flexible Endoscope Overall Volume (2000-2012)
  • 5.3 Flexible Endoscope Average Price (2000-2012)
  • 5.4 Flexible Endoscope Distribution Share (2006-2007)
  • 5.5 Flexible Endoscope Company Share (2006-2007)
• 6 Rigid Endoscope in Canada
  • 6.1 Rigid Endoscope Overall Revenues (2000-2012)
  • 6.2 Rigid Endoscope Overall Volume (2000-2012)
  • 6.3 Rigid Endoscope Average Price (2000-2012)
  • 6.4 Rigid Endoscope Distribution Share (2006-2007)
  • 6.5 Rigid Endoscope Company Share (2006-2007
• 7 OLYMPUS CORPORATION Company Profile
  • 7.1 Company Overview
  • 7.2 Business Overview
    • 7.2.1 Imaging Systems Business
      • 7.2.1.1 Overview
      • 7.2.1.2 Financials
      • 7.2.1.3 Capital Expenditure
      • 7.2.1.4 Market View
      • 7.2.1.5 Key Strategies
    • 7.2.2 Information and Communication Business
      • 7.2.2.1 Overview
      • 7.2.2.2 Financials
      • 7.2.2.3 Capital Expenditure
      • 7.2.2.4 Key Strategies
    • 7.2.3 Life Sciences Business
      • 7.2.3.1 Overview
      • 7.2.3.2 Financials
      • 7.2.3.3 Capital Expenditure
      • 7.2.3.4 Market View
      • 7.2.3.5 Key Strategies
    • 7.2.4 Medical Systems Business
      • 7.2.4.1 Overview
      • 7.2.4.2 Financials
      • 7.2.4.3 Capital Expenditure
      • 7.2.4.4 Market View
      • 7.2.4.5 Key Strategies
    • 7.2.5 Others
      • 7.2.5.1 Overview
      • 7.2.5.2 Financials
      • 7.2.5.3 Capital Expenditure
      • 7.2.5.4 Market View
      • 7.2.5.5 Key Strategies
    • 7.2.6 Major Products and Services
    • 7.2.7 History
  • 7.3 Value Chain Analysis
    • 7.3.1 Manufacturing
      • 7.3.1.1 In House Manufacturing
    • 7.3.2 Product Development
      • 7.3.2.1 Regulatory Approvals
      • 7.3.2.2 Research and Development
    • 7.3.3 Sales and Marketing
      • 7.3.3.1 Partnerships and Alliances
      • 7.3.3.2 Licensing Agreements
      • 7.3.3.3 E-distribution
  • 7.4 SWOT Analysis
    • 7.4.1 OLYMPUS CORPORATION Strengths
      • 7.4.1.1 Expansion of business activities
      • 7.4.1.2 Strong internal control system
      • 7.4.1.3 Strong financial performance
    • 7.4.2 OLYMPUS CORPORATION Weaknesses
      • 7.4.2.1 Sluggish growth in Imaging Systems Business division
      • 7.4.2.2 Weak presence in Asia
      • 7.4.2.3 Inconsistent profit margin
    • 7.4.3 OLYMPUS CORPORATION Opportunities
      • 7.4.3.1 Focused R&D
      • 7.4.3.2 Launching of new products
      • 7.4.3.3 Expansion of global markets
    • 7.4.4 OLYMPUS CORPORATION Threats
      • 7.4.4.1 Price competition
      • 7.4.4.2 Dependent on key suppliers
      • 7.4.4.3 Pricing pressures in Japan
  • 7.5 Revenue Analysis
    • 7.5.1 Revenue by Segment
    • 7.5.2 Revenue by Geography
  • 7.6 Financial and Operational Review
    • 7.6.1 Financial Statements
    • 7.6.2 Financial Ratios
    • 7.6.3 Share Holding Structure
  • 7.7 Locations And Subsidiaries
  • 7.8 Financial Deals Landscape
    • 7.8.1 Spiration Secures $18.5 Million In Series G Round Of Financing
    • 7.8.2 Terumo Forms Joint Venture With Olympus Corporation
    • 7.8.3 Olympus Signs An Agreement With Visen Medical
    • 7.8.4 Olympus Acquires Stake In Cytori Therapeutics
    • 7.8.5 Olympus Corporation Forms A Joint Venture With Movaz Networks
    • 7.8.6 Spiration Secures $13.4 Million In Series F Financing
    • 7.8.7 Olympus Corporation Forms Partnership With Takano
    • 7.8.8 Olympus To Acquire Gyrus Group
  • 7.9 Recent Developments
    • 7.9.1 Apr 01, 2008: Olympus Appoints New CEO
    • 7.9.2 Feb 04, 2008: Olympus Reports Q3 Fiscal 2008 Results
    • 7.9.3 Nov 06, 2007: Olympus Reports Q2 Fiscal 2008 Results
    • 7.9.4 Jul 30, 2007: Olympus Reports Q1 Fiscal 2008 Results
    • 7.9.5 Jul 30, 2007: Olympus Reports H1 Fiscal 2006 Results
    • 7.9.6 Jul 30, 2007: Olympus Reports Q1 Fiscal 2006 Results
    • 7.9.7 Jul 30, 2007: Olympus Reports Fiscal 2006 Results
    • 7.9.8 Jul 30, 2007: Olympus Reports Q3 Fiscal 2006 Results
    • 7.9.9 Jul 30, 2007: Olympus Reports Q1 Fiscal 2007 Results
    • 7.9.10 May 08, 2007: Olympus Reports Fiscal 2007 Results
    • 7.9.11 Feb 05, 2007: Olympus Reports Q3 Fiscal 2007 Results
  • 7.10 OLYMPUS CORPORATION Pipeline Products
    • 7.10.1 OLYMPUS CAPSULE ENDOSCOPE SYSTEM
      • 7.10.1.1 Product Overview
      • 7.10.1.2 Product Description
      • 7.10.1.3 Product Status
    • 7.10.2 Single Balloon Enteroscopy (SBE) system
      • 7.10.2.1 Product Overview
      • 7.10.2.2 Product Description
      • 7.10.2.3 Product Status
      • 7.10.2.4 Product Milestone
• 8 KARL STORZ GmbH & Co. KG Company Profile
  • 8.1 Company Overview
  • 8.2 Business Overview
    • 8.2.1 Major Products and Services
    • 8.2.2 History
  • 8.3 Locations And Subsidiaries
  • 8.4 Financial Deals Landscape
    • 8.4.1 KARL STORZ Signs An Agreement With EndoGastric Solutions
• 9 PENTAX Medical Company Profile
  • 9.1 Company Overview
  • 9.2 Business Overview
    • 9.2.1 Major Products and Services
    • 9.2.2 History
  • 9.3 Locations And Subsidiaries
  • 9.4 Financial Deals Landscape
    • 9.4.1 PENTAX Medical Company Acquires Operating Assets Of KayPENTAX (formerly Kay Elemetrics)
  • 9.5 Recent Developments
    • 9.5.1 Oct 06, 2007: PENTAX Appoints VP, Sales And Marketing
• 10 B. Braun Melsungen AG Company Profile
  • 10.1 Company Overview
  • 10.2 Business Overview
    • 10.2.1 Aesculap division
      • 10.2.1.1 Overview
      • 10.2.1.2 Financials
      • 10.2.1.3 Market View
      • 10.2.1.4 Key Strategies
    • 10.2.2 B. Braun Avitum division
      • 10.2.2.1 Overview
      • 10.2.2.2 Financials
      • 10.2.2.3 Market View
      • 10.2.2.4 Key Strategies
    • 10.2.3 Hospital Care division
      • 10.2.3.1 Overview
      • 10.2.3.2 Financials
      • 10.2.3.3 Key Strategies
    • 10.2.4 Out Patient Market (OPM) division
      • 10.2.4.1 Overview
      • 10.2.4.2 Financials
      • 10.2.4.3 Market View
      • 10.2.4.4 Key Strategies
    • 10.2.5 Major Products and Services
    • 10.2.6 History
  • 10.3 Value Chain Analysis
    • 10.3.1 Manufacturing
      • 10.3.1.1 In House Manufacturing
      • 10.3.1.2 Outsourcing
    • 10.3.2 Product Development
      • 10.3.2.1 Regulatory Approvals
      • 10.3.2.2 Clinical Trials
      • 10.3.2.3 Research and Development
    • 10.3.3 Sales and Marketing
      • 10.3.3.1 Partnerships and Alliances
      • 10.3.3.2 Licensing Agreements
  • 10.4 SWOT Analysis
    • 10.4.1 B. Braun Melsungen AG Strengths
      • 10.4.1.1 L.I.F.E certification
      • 10.4.1.2 Significant revenues
      • 10.4.1.3 Worldwide existence
    • 10.4.2 B. Braun Melsungen AG Weaknesses
      • 10.4.2.1 High SG&A expenses
      • 10.4.2.2 FDA warning letter
    • 10.4.3 B. Braun Melsungen AG Opportunities
      • 10.4.3.1 Acquisitions
      • 10.4.3.2 Expansion of business
      • 10.4.3.3 Broad product portfolio
    • 10.4.4 B. Braun Melsungen AG Threats
      • 10.4.4.1 Foreign exchange
      • 10.4.4.2 Intense competition and change in technologies
  • 10.5 Revenue Analysis
    • 10.5.1 Revenue by Segment
    • 10.5.2 Revenue by Geography
  • 10.6 Financial and Operational Review
    • 10.6.1 Financial Statements
    • 10.6.2 Financial Ratios
  • 10.7 Locations And Subsidiaries
  • 10.8 Financial Deals Landscape
    • 10.8.1 B. Braun Signs An Agreement With Nipro
    • 10.8.2 B. Braun Enters Into A Licensing Agreement With Chartie Hospital
    • 10.8.3 B. Braun Signs An Agreement With Charite
  • 10.9 Recent Developments
    • 10.9.1 Mar 26, 2008: B. Braun Reports 2007 Results
    • 10.9.2 Oct 25, 2007: B. Braun Melsungen Signs Distribution Agreement With NIPRO
    • 10.9.3 May 25, 2007: B. Braun Melsungen Enters Into Strategic Alliance With Health Robotics
    • 10.9.4 Mar 28, 2007: B. Braun Melsungen Reports 2006 Results
    • 10.9.5 Mar 24, 2007: B. Braun Melsungen To Shut Its Plant In Puerto Rico
    • 10.9.6 Mar 15, 2007: B. Braun Melsungen To Invest In Medical Technology Production
    • 10.9.7 Sep 19, 2005: B. Braun Medical Opens Manufacturing Facility In Suzhou
  • 10.10 B. Braun Melsungen AG Pipeline Products
    • 10.10.1 Coroflex Please
      • 10.10.1.1 Product Overview
      • 10.10.1.2 Product Description
      • 10.10.1.3 Product Status
      • 10.10.1.4 Product Milestone
    • 10.10.2 SeQuent Please
      • 10.10.2.1 Product Overview
      • 10.10.2.2 Product Description
      • 10.10.2.3 Product Status
• 11 Fujinon Corporation Company Profile
  • 11.1 Company Overview
  • 11.2 Business Overview
    • 11.2.1 Major Products and Services
    • 11.2.2 History
  • 11.3 Locations And Subsidiaries
  • 11.4 Financial Deals Landscape
    • 11.4.1 Given Imaging And Fujinon Corporation Sign Global Strategic Collaboration
  • 11.5 Recent Developments
    • 11.5.1 Jul 11, 2006: Fujinon Reports Fiscal 2007 Results
• 12 Regulation System
  • 12.1 Medical Equipment Approval Process
    • 12.1.1 Classification
    • 12.1.2 Conformity Assessment
      • 12.1.2.1 Class II
      • 12.1.2.2 Class III
      • 12.1.2.3 Class IV
    • 12.1.3 License Fee
    • 12.1.4 License Application Processing Duration
  • 12.2 Labeling and Packaging
  • 12.3 Post-Market Surveillance
• 13 Pricing and Reimbursement
  • 13.1 Canada Medical Equipment Pricing and Reimbursement
• 14 Distribution Structure
  • 14.1 Canada Medical Equipment Distribution Structure
• 15 APPENDIX
  • 15.1 Global Markets Direct Research Methodology
  • 15.2 Coverage
  • 15.3 Secondary Research
  • 15.4 Primary Research
  • 15.5 Models
  • 15.6 Forecasts
  • 15.7 Expert Panels
  • 15.8 Currency Conversion
  • 15.9 Contact Us
  • 15.10 Disclaimer
• LIST OF TABLES
• List of Tables
  • Table 1: Number of Physicians by Province in Canada, 2001 and 2005
  • Table 2: Hospital Wards by Specialty in Canada, 2003-2007
  • Table 3: Doctors by Specialty in Canada, 2003-2007
  • Table 4: Endoscopy Devices, Canada, Overall Revenues ($ mn), 2000-2012
  • Table 5: Endoscopy Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 6: Endoscopy Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 7: Endoscopy Devices, Canada, Category Revenues ($ mn), 2000-2012
  • Table 8: Endoscopy Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007
  • Table 9: Endoscopy Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012
  • Table 10: Endoscopy Devices, Canada, Category Volume (Units), 2000-2012
  • Table 11: Endoscopy Devices, Canada, Category Volume (Units), Historic, 2000-2007
  • Table 12: Endoscopy Devices, Canada, Category Volume (Units), Forecast, 2007-2012
  • Table 13: Endoscopy Devices, Canada, Company Share by Revenue ($ mn), 2006-2007
  • Table 14: Flexible Endoscope, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 15: Flexible Endoscope, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 16: Flexible Endoscope, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 17: Flexible Endoscope, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 18: Flexible Endoscope, Canada, Average Price ($), Historic, 2000-2007
  • Table 19: Flexible Endoscope, Canada, Average Price ($), Forecast, 2007-2012
  • Table 20: Flexible Endoscope, Canada, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 21: Flexible Endoscope, Canada, Company Share by Revenue ($ mn), 2006-2007
  • Table 22: Rigid Endoscope, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Table 23: Rigid Endoscope, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Table 24: Rigid Endoscope, Canada, Overall Volume (Units), Historic, 2000-2007
  • Table 25: Rigid Endoscope, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Table 26: Rigid Endoscope, Canada, Average Price ($), Historic, 2000-2007
  • Table 27: Rigid Endoscope, Canada, Average Price ($), Forecast, 2007-2012
  • Table 28: Rigid Endoscope, Canada, Distribution Share by Revenue ($ mn), 2006-2007
  • Table 29: Rigid Endoscope, Canada, Company Share by Revenue ($ mn), 2006-2007
  • Table 30: OLYMPUS CORPORATION, SWOT Analysis, 2007
  • Table 31: OLYMPUS CORPORATION, Revenue by Segment, Yen Million, 2003-2007
  • Table 32: OLYMPUS CORPORATION, Revenue by Geography, Yen Million, 2003-2007
  • Table 33: OLYMPUS CORPORATION, Financial Statements, Yen Million, 2003-2007
  • Table 34: OLYMPUS CORPORATION, Financial Ratios, Yen Million, 2003-2007
  • Table 35: OLYMPUS CORPORATION, Share Holding Structure
  • Table 36: OLYMPUS CORPORATION, Other Locations
  • Table 37: OLYMPUS CORPORATION, Other Locations(Contd..)
  • Table 38: OLYMPUS CORPORATION, Subsidiaries
  • Table 39: KARL STORZ GmbH & Co. KG, Other Locations
  • Table 40: KARL STORZ GmbH & Co. KG, Other Locations(Contd..)
  • Table 41: PENTAX Medical Company, Other Locations
  • Table 42: B. Braun Melsungen AG, SWOT Analysis, 2006
  • Table 43: B. Braun Melsungen AG, Revenue by Segment, Euro Thousand, 2002-2006
  • Table 44: B. Braun Melsungen AG, Revenue by Geography, Euro Thousand, 2002-2006
  • Table 45: B. Braun Melsungen AG, Financial Statements, Euro Thousand, 2002-2006
  • Table 46: B. Braun Melsungen AG, Financial Ratios, Euro Thousand, 2002-2006
  • Table 47: B. Braun Melsungen AG, Subsidiaries
  • Table 48: B. Braun Melsungen AG, Subsidiaries(Contd..)
  • Table 49: Fujinon Corporation, Subsidiaries
  • Table 50: Medical Equipment Classification in Canada, 2007
  • Table 51: Medical Equipment Licensing Fee in Canada, 2007
  • Table 52: Medical Equipment License Processing Duration in Canada, 2007
  • Table 53: Currency Conversion from USD to Local Currency at 2007 Constant Rate
• LIST OF FIGURES
• List of Figures
  • Figure 1: Healthcare Financing in Canada, 2004
  • Figure 2: Healthcare Expenditure in Canada, 2000 - 2006
  • Figure 3: Endoscopy Devices, Canada, Overall Revenues ($ mn), 2000-2012
  • Figure 4: Endoscopy Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 5: Endoscopy Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 6: Endoscopy Devices, Canada, Category Revenues ($ mn), 2000-2012
  • Figure 7: Endoscopy Devices, Canada, Category Revenues ($ mn), Historic, 2000-2007
  • Figure 8: Endoscopy Devices, Canada, Category Revenues ($ mn), Forecast, 2007-2012
  • Figure 9: Endoscopy Devices, Canada, Category Volume (Units), 2000-2012
  • Figure 10: Endoscopy Devices, Canada, Category Volume (Units), Historic, 2000-2007
  • Figure 11: Endoscopy Devices, Canada, Category Volume (Units), Forecast, 2007-2012
  • Figure 12: Endoscopy Devices, Canada, Company Share (%), 2007
  • Figure 13: Flexible Endoscope, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 14: Flexible Endoscope, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 15: Flexible Endoscope, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 16: Flexible Endoscope, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 17: Flexible Endoscope, Canada, Average Price ($), Historic, 2000-2007
  • Figure 18: Flexible Endoscope, Canada, Average Price ($), Forecast, 2007-2012
  • Figure 19: Flexible Endoscope, Canada, Distribution Share (%), 2007
  • Figure 20: Flexible Endoscope, Canada, Company Share (%), 2007
  • Figure 21: Rigid Endoscope, Canada, Overall Revenues ($ mn), Historic, 2000-2007
  • Figure 22: Rigid Endoscope, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
  • Figure 23: Rigid Endoscope, Canada, Overall Volume (Units), Historic, 2000-2007
  • Figure 24: Rigid Endoscope, Canada, Overall Volume (Units), Forecast, 2007-2012
  • Figure 25: Rigid Endoscope, Canada, Average Price ($), Historic, 2000-2007
  • Figure 26: Rigid Endoscope, Canada, Average Price ($), Forecast, 2007-2012
  • Figure 27: Rigid Endoscope, Canada, Distribution Share (%), 2007
  • Figure 28: Rigid Endoscope, Canada, Company Share (%), 2007
  • Figure 29: OLYMPUS CORPORATION, Value Chain Analysis
  • Figure 30: B. Braun Melsungen AG, Value Chain Analysis
  • Figure 31: Global Markets Direct Methodology